AZN

Supply shortages have complicated the pharmaceutical industry. Eli Lilly & Co are making the right pivots. New partnerships aimed at new products show great promise. The dividend is healthy, and long-term growth looks good. 5 stocks we like better than Eli Lilly and Heading into the week before Christmas, the United States Food and Drug […]
https://www.valuewalk.com/eli-lilly-expects-enduring-growth-despite-immediate-challenges/